{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:08:57Z","timestamp":1784066937375,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2025R48"],"award-info":[{"award-number":["RSP2025R48"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22238001"],"award-info":[{"award-number":["22238001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22378016"],"award-info":[{"award-number":["22378016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22322802"],"award-info":[{"award-number":["22322802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0918000"],"award-info":[{"award-number":["2024YFA0918000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lfs.2025.123814","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T17:35:22Z","timestamp":1750613722000},"page":"123814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Integrative machine learning and structure-based drug repurposing for identifying potent inhibitors of human SYK activity against cancer"],"prefix":"10.1016","volume":"378","author":[{"given":"Muhammad Waleed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghul Subin","family":"Sasidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Zeeshan","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Al-Ghanim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zohaib","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"10295","key":"10.1016\/j.lfs.2025.123814_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(21)00233-6","article-title":"Contemporary radiotherapy: present and future","volume":"398","author":"Chandra","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0015","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3390\/curroncol28050344","article-title":"Breast cancer surgery: new issues","volume":"28","author":"Magnoni","year":"2021","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/diseases10030060","article-title":"Emerging trends in immunotherapy for cancer","volume":"10","author":"Mishra","year":"2022","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0025","first-page":"1","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2025.123814_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12940-020-00670-2","article-title":"Environmental chemicals, breast cancer progression and drug resistance","volume":"19","author":"Koual","year":"2020","journal-title":"Environ. Health"},{"key":"10.1016\/j.lfs.2025.123814_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.666528","article-title":"Ultraviolet radiation and basal cell carcinoma: an environmental perspective","volume":"9","author":"Teng","year":"2021","journal-title":"Front. Public Health"},{"issue":"6","key":"10.1016\/j.lfs.2025.123814_bb0040","first-page":"460","article-title":"Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations","volume":"70","author":"Turner","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2025.123814_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5905357","article-title":"Tobacco smoking and liver cancer risk: potential avenues for carcinogenesis","volume":"2021","author":"Jain","year":"2021","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02787340","article-title":"How do mutated oncogenes and tumor suppressor genes cause cancer?","volume":"15","author":"Grand\u00e9r","year":"1998","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0055","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in cell death and human cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1200\/JCO.2005.03.139","article-title":"Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non\u2013small-cell lung cancer","volume":"23","author":"Wang","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00795-012-0575-6","article-title":"Overexpression of p53 protein in human tumors","volume":"45","author":"Inoue","year":"2012","journal-title":"Med. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.lfs.2025.123814_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164050","article-title":"Unlocking the potential of kinase targets in cancer: insights from CancerOmicsNet, an AI-driven approach to drug response prediction in cancer","volume":"15","author":"Singha","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.lfs.2025.123814_bb0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cas.13551","article-title":"Roles of protein kinase R in cancer: potential as a therapeutic target","volume":"109","author":"Watanabe","year":"2018","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0090","first-page":"582","article-title":"Linking inflammation and cancer: the unexpected SYK world","volume":"20","author":"Fueyo","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbamcr.2014.10.022","article-title":"Calling in SYK: SYK\u2019s dual role as a tumor promoter and tumor suppressor in cancer","volume":"1853","author":"Krisenko","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"20","key":"10.1016\/j.lfs.2025.123814_bb0100","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1158\/0008-5472.CAN-03-3520","article-title":"Progressive loss of Syk and abnormal proliferation in breast cancer cells","volume":"64","author":"Moroni","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/bcr261","article-title":"Syk: a new player in the field of breast cancer","volume":"3","author":"Stewart","year":"2001","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0110","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/j.gastro.2016.01.034","article-title":"C-type lectin-like receptor 2 suppresses AKT signaling and invasive activities of gastric cancer cells by blocking expression of phosphoinositide 3-kinase subunits","volume":"150","author":"Wang","year":"2016","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.lfs.2025.123814_bb0115","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1158\/0008-5472.CAN-08-4252","article-title":"Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia","volume":"69","author":"Buchner","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2025.123814_bb0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.lfs.2025.123814_bb0125","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2010-03-275180","article-title":"The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the E\u03bc-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling","volume":"116","author":"Suljagic","year":"2010","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.lfs.2025.123814_bb0130","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2014-08-595934","article-title":"An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia","volume":"125","author":"Sharman","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-017-0512-1","article-title":"Syk inhibitors in clinical development for hematological malignancies","volume":"10","author":"Liu","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"D1","key":"10.1016\/j.lfs.2025.123814_bb0140","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2025.123814_bb0145","first-page":"1","article-title":"An open source chemical structure curation pipeline using RDKit","volume":"12","author":"Bento","year":"2020","journal-title":"J. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2025.123814_bb0150","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/cbdv.200900117","article-title":"Recent advances in physicochemical and ADMET profiling in drug discovery","volume":"6","author":"Wang","year":"2009","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0155","first-page":"1104","article-title":"Tool development for prediction of pIC50 values from the IC50 values-a pIC50 value calculator","volume":"5","author":"Selvaraj","year":"2011","journal-title":"Curr. Trends Biotechnol. Pharm."},{"key":"10.1016\/j.lfs.2025.123814_bb0160","series-title":"Matplotlib and Seaborn. Building Machine Learning and Deep Learning Models on Google Cloud Platform: A Comprehensive Guide for Beginners","first-page":"151","author":"Bisong","year":"2019"},{"issue":"7","key":"10.1016\/j.lfs.2025.123814_bb0165","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.lfs.2025.123814_bb0175","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2025.123814_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.eswa.2016.12.008","article-title":"Automatic selection of molecular descriptors using random forest: application to drug discovery","volume":"72","author":"Cano","year":"2017","journal-title":"Expert Syst. Appl."},{"key":"10.1016\/j.lfs.2025.123814_bb0185","series-title":"Neural Networks Vs. Random Forests\u2013Does It Always Have to Be Deep Learning","first-page":"1","author":"Ro\u00dfbach","year":"2018"},{"key":"10.1016\/j.lfs.2025.123814_bb0190","series-title":"Distributed Machine Learning With PySpark: Migrating Effortlessly From Pandas and Scikit-Learn","first-page":"243","article-title":"Random Forest classification with Scikit-Learn and PySpark","author":"Testas","year":"2023"},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0195","article-title":"Investigating the impact of train\/test split ratio on the performance of pre-trained models with custom datasets","volume":"15","author":"Bichri","year":"2024","journal-title":"Int. J. Adv. Comput. Sci. Appl."},{"key":"10.1016\/j.lfs.2025.123814_bb0200","series-title":"2021 4th International Conference of Computer and Informatics Engineering (IC2IE)","article-title":"Hyperparameter tuning using GridsearchCV on the comparison of the activation function of the ELM method to the classification of pneumonia in toddlers","author":"Kartini","year":"2021"},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0205","first-page":"183","article-title":"Comparison of machine learning land use-land cover supervised classifiers performance on satellite imagery sentinel 2 using lazy predict library","volume":"4","author":"Putra","year":"2023","journal-title":"Indones. J. Data Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0304-4076(96)01818-0","article-title":"An R-squared measure of goodness of fit for some common nonlinear regression models","volume":"77","author":"Cameron","year":"1997","journal-title":"J. Econ."},{"key":"10.1016\/j.lfs.2025.123814_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.enconman.2022.115526","article-title":"Experimental comparison between various fitting approaches based on RMSE minimization for photovoltaic module parametric identification","volume":"258","author":"Lappalainen","year":"2022","journal-title":"Energy Convers. Manag."},{"key":"10.1016\/j.lfs.2025.123814_bb0220","series-title":"Molecular Modeling of Proteins","first-page":"365","article-title":"Molecular docking","author":"Morris","year":"2008"},{"key":"10.1016\/j.lfs.2025.123814_bb0225","series-title":"Protein Crystallography: Methods and Protocols","first-page":"627","article-title":"Protein Data Bank (PDB): the single global macromolecular structure archive","author":"Burley","year":"2017"},{"issue":"4","key":"10.1016\/j.lfs.2025.123814_bb0230","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1080\/07391102.2023.2202247","article-title":"In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19","volume":"42","author":"Gutti","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11120-020-00741-y","article-title":"Molecular dynamics simulations in photosynthesis","volume":"144","author":"Liguori","year":"2020","journal-title":"Photosynth. Res."},{"issue":"8","key":"10.1016\/j.lfs.2025.123814_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104822","article-title":"A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites","volume":"9","author":"Galli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.123814_bb0245","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijbiomac.2022.06.014","article-title":"Discovery and characterization of dual inhibitors of human Vanin-1 and Vanin-2 enzymes through molecular docking and dynamic simulation-based approach","volume":"213","author":"Nawaz","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/molecules22010136","article-title":"The performance of several docking programs at reproducing protein\u2013macrolide-like crystal structures","volume":"22","author":"Castro-Alvarez","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2025.123814_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.procbio.2021.08.015","article-title":"Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach","volume":"110","author":"Alghamdi","year":"2021","journal-title":"Process Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0260","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0265","doi-asserted-by":"crossref","DOI":"10.2196\/14232","article-title":"Molecular docking using chimera and autodock vina software for nonbioinformaticians","volume":"1","author":"Butt","year":"2020","journal-title":"JMIR Bioinform. Biotechnol."},{"issue":"16","key":"10.1016\/j.lfs.2025.123814_bb0270","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1080\/10408398.2017.1341864","article-title":"Application of molecular dynamic simulation to study food proteins: a review","volume":"58","author":"Singh","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"13","key":"10.1016\/j.lfs.2025.123814_bb0275","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1080\/07391102.2022.2098823","article-title":"Evaluating the accuracy of the AMBER protein force fields in modeling dihydrofolate reductase structures: misbalance in the conformational arrangements of the flexible loop domains","volume":"41","author":"Love","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0280","first-page":"2001","article-title":"Antechamber: an accessory software package for molecular mechanical calculations","volume":"222","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2025.123814_bb0285","series-title":"Topology File Tutorial","author":"Oakley","year":"2007"},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0290","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/07391102.1991.10507930","article-title":"Molecular modeling of proteins: a strategy for energy minimization by molecular mechanics in the AMBER force field","volume":"9","author":"Kini","year":"1991","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.lfs.2025.123814_bb0295","doi-asserted-by":"crossref","DOI":"10.1063\/1.4978807","article-title":"Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation","volume":"146","author":"Lin","year":"2017","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.lfs.2025.123814_bb0300","doi-asserted-by":"crossref","DOI":"10.1063\/1.4954990","article-title":"A simple and accurate algorithm for path integral molecular dynamics with the Langevin thermostat","volume":"145","author":"Liu","year":"2016","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0305","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","author":"Kr\u00e4utler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/00268979000100341","article-title":"Vapour liquid equilibrium of a pure fluid from test particle method in combination with NpT molecular dynamics simulations","volume":"69","author":"M\u00f6ller","year":"1990","journal-title":"Mol. Phys."},{"key":"10.1016\/j.lfs.2025.123814_bb0315","series-title":"LITP Spring School on Theoretical Computer Science","first-page":"21","article-title":"Amber","author":"Cardelli","year":"1985"},{"issue":"7","key":"10.1016\/j.lfs.2025.123814_bb0320","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.lfs.2025.123814_bb0325","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2025.123814_bb0330","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-981-15-6815-2_7","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes","author":"Shukla","year":"2020","journal-title":"Comput-Aided Drug Des."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0335","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/biomedicines11030793","article-title":"Identification of natural lead compounds against hemagglutinin-esterase surface glycoprotein in human coronaviruses investigated via MD simulation, principal component analysis, cross-correlation, H-bond plot and MMGBSA","volume":"11","author":"Ali","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.lfs.2025.123814_bb0340","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2025.123814_bb0345","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and use of the MM-PBSA approach for drug discovery","volume":"48","author":"Kuhn","year":"2005","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2025.123814_bb0350","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?","volume":"16","author":"Tuccinardi","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0355","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.lfs.2025.123814_bb0360","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/acs.jcim.8b00550","article-title":"Application of bioactivity profile-based fingerprints for building machine learning models","volume":"59","author":"Sturm","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.lfs.2025.123814_bb0365","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/ci8001556","article-title":"Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA","volume":"48","author":"Cramer","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2025.123814_bb0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00210-001-0521-y","article-title":"Rat NKCC2\/NKCC1 cotransporter selectivity for loop diuretic drugs","volume":"365","author":"Hannaert","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2025.123814_bb0375","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10822-016-9912-5","article-title":"The analysis of the market success of FDA approvals by probing top 100 bestselling drugs","volume":"30","author":"Polanski","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.lfs.2025.123814_bb0380","series-title":"Computational Modelling of Drugs for Alzheimer\u2019s Disease (Ad) and Applications on Artifical Neural Network Systems (Nets)","author":"Masarweh","year":"2021"},{"issue":"5","key":"10.1016\/j.lfs.2025.123814_bb0385","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/C1MD00017A","article-title":"Molecular obesity, potency and other addictions in drug discovery","volume":"2","author":"Hann","year":"2011","journal-title":"MedChemComm"},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0390","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40265-013-0159-3","article-title":"Darunavir: a review of its use in the management of HIV-1 infection","volume":"74","author":"Deeks","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2025.123814_bb0395","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2165\/00003495-200767180-00010","article-title":"Darunavir: in the treatment of HIV-1 infection","volume":"67","author":"Fenton","year":"2007","journal-title":"Drugs"},{"issue":"Supplement_1","key":"10.1016\/j.lfs.2025.123814_bb0400","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/clinids\/22.Supplement_1.S37","article-title":"Rifabutin therapy for disseminated Mycobacterium avium complex infection","volume":"22","author":"Sullam","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0405","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00006454-199801000-00016","article-title":"Rifabutin","volume":"17","author":"Mofenson","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"4","key":"10.1016\/j.lfs.2025.123814_bb0410","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/ciia.2006.1.4.403","article-title":"Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence","volume":"1","author":"Hatzimouratidis","year":"2006","journal-title":"Clin. Interv. Aging"},{"issue":"10","key":"10.1016\/j.lfs.2025.123814_bb0415","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199809033391011","article-title":"Sildenafil in the treatment of erectile dysfunction","volume":"339","author":"Shah","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123814_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2020","journal-title":"Processes"},{"issue":"8","key":"10.1016\/j.lfs.2025.123814_bb0425","doi-asserted-by":"crossref","DOI":"10.1063\/1.4986552","article-title":"Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations","volume":"147","author":"Liu","year":"2017","journal-title":"J. Chem. Phys."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2025.123814_bb0430","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0301-0104(95)00267-7","article-title":"Hydrogen bond analysis by MD simulation of copper plastocyanin at different hydration levels","volume":"201","author":"Bizzarri","year":"1995","journal-title":"Chem. Phys."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2025.123814_bb0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molliq.2009.01.009","article-title":"Hydrogen bonding analysis of glycerol aqueous solutions: a molecular dynamics simulation study","volume":"146","author":"Chen","year":"2009","journal-title":"J. Mol. Liq."},{"issue":"13\u201314","key":"10.1016\/j.lfs.2025.123814_bb0440","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","article-title":"Spleen tyrosine kinases: biology, therapeutic targets and drugs","volume":"15","author":"Riccaboni","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2025.123814_bb0445","series-title":"Bioinformatics and Biomedical Engineering: 5th International Work-Conference, IWBBIO 2017, Granada, Spain, April 26\u201328, 2017, Proceedings, Part I 5","article-title":"Immune network technology on the basis of random forest algorithm for computer-aided drug design","author":"Samigulina","year":"2017"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:49:51Z","timestamp":1773294591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525004497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":89,"alternative-id":["S0024320525004497"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123814","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative machine learning and structure-based drug repurposing for identifying potent inhibitors of human SYK activity against cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123814"}}